Kapanol (Morphine Sulfate)
Kapanol morphine sulphate and Kadian capsules are a sustained-release oral formulation of morphine sulphate indicated for the management of moderate to severe chronic pain.
Kapanol’s and Kadian’s drug delivery profile is achieved with Mayne Pharma’s sustained-release pellet technology. This provides patients with smooth steady-state plasma levels for consistent pain relief.
Kapanol and Kadian capsules may be dosed once or twice daily to maintain therapeutic blood levels and is available in a number of flexible modes of administration (capsules, sprinkle and G-tube) and doses (10 mg, 20 mg, 50 mg and 100 mg in Australia, Canada and various other international territories).
Internationally, Kapanol capsules are currently licensed to Zuellig in Thailand, Spirig Healthcare in Switzerland and also sold in Canada by Mylan (as Kadian) and in Japan by Dainippon (as Kadian). Kapanol morphine sulphate
Opportunities remain for licensing in a significant number of international territories.